Literature DB >> 17334730

HIV infection with concomitant cerebral toxoplasmosis and disseminated histoplasmosis in a 45-year-old man.

Masayuki Murata1, Norihiro Furusyo, Shigeru Otaguro, Shigeki Nabeshima, Iwao Ariyama, Jun Hayashi.   

Abstract

Although disseminated histoplasmosis is a common opportunistic infection in HIV patients in endemic areas, it is not widely known in Japan. We report a rare case of a man from Ghana infected with HIV who was hospitalized in Japan and who suffered from coinfection with cerebral toxoplasmosis and disseminated histoplasmosis. The diagnosis of cerebral toxoplasmosis was confirmed by a brain biopsy, and the therapy for the disease resulted in almost complete resolution of the brain lesion. However, fever of unknown origin continued for 2 weeks, and disseminated histoplasmosis was diagnosed by examination of a blood smear and by the detection of the histoplasma genome in the peripheral blood by means of polymerase chain reaction. The isolate was confirmed to be Histoplasma capsulatum var. duboisii. Therapy with amphotericin B was initiated, and no histoplasma genome in the peripheral blood was detected 3 days later. Unfortunately, the patient died after 10 days from acute respiratory syndrome. This case highlights that histoplasmosis should be included in the differential diagnosis of opportunistic infections in AIDS patients when patients have a history of travel to or arrival from endemic areas.

Entities:  

Mesh:

Year:  2007        PMID: 17334730      PMCID: PMC7101794          DOI: 10.1007/s10156-006-0486-3

Source DB:  PubMed          Journal:  J Infect Chemother        ISSN: 1341-321X            Impact factor:   2.211


  15 in total

1.  Case report. Toxoplasma encephalitis after initiation of HAART.

Authors:  P E Tsambiras; J A Larkin; S H Houston
Journal:  AIDS Read       Date:  2001-12

Review 2.  Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature.

Authors:  L J Wheat; P A Connolly-Stringfield; R L Baker; M F Curfman; M E Eads; K S Israel; S A Norris; D H Webb; M L Zeckel
Journal:  Medicine (Baltimore)       Date:  1990-11       Impact factor: 1.889

Review 3.  Imported mycoses: an update.

Authors:  Makoto Miyaji; Katsuhiko Kamei
Journal:  J Infect Chemother       Date:  2003-06       Impact factor: 2.211

4.  Practice guidelines for the management of patients with histoplasmosis. Infectious Diseases Society of America.

Authors:  J Wheat; G Sarosi; D McKinsey; R Hamill; R Bradsher; P Johnson; J Loyd; C Kauffman
Journal:  Clin Infect Dis       Date:  2000-04-20       Impact factor: 9.079

5.  The prevalence and risk of immune restoration disease in HIV-infected patients treated with highly active antiretroviral therapy.

Authors:  D J Jevtović; D Salemović; J Ranin; I Pesić; S Zerjav; O Djurković-Djaković
Journal:  HIV Med       Date:  2005-03       Impact factor: 3.180

6.  Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.

Authors:  F J Palella; K M Delaney; A C Moorman; M O Loveless; J Fuhrer; G A Satten; D J Aschman; S D Holmberg
Journal:  N Engl J Med       Date:  1998-03-26       Impact factor: 91.245

7.  Incidence of acquired immunodeficiency syndrome-associated opportunistic diseases and the effect of treatment on a cohort of 1115 patients infected with human immunodeficiency virus, 1989-1997.

Authors:  Francisco-Javier San-Andrés; Rafael Rubio; Jesús Castilla; Federico Pulido; Guillermo Palao; Inmaculada de Pedro; José-Ramón Costa; Angel del Palacio
Journal:  Clin Infect Dis       Date:  2003-04-14       Impact factor: 9.079

8.  Prevalence, associated factors, and prognostic determinants of AIDS-related toxoplasmic encephalitis in the era of advanced highly active antiretroviral therapy.

Authors:  Andrea Antinori; Dora Larussa; Antonella Cingolani; Patrizia Lorenzini; Simona Bossolasco; Maria Grazia Finazzi; Marco Bongiovanni; Giovanni Guaraldi; Susanna Grisetti; Beniamino Vigo; Beniamino Gigli; Andrea Mariano; Ernesto Renato Dalle Nogare; Michele De Marco; Francesca Moretti; Paola Corsi; Nicola Abrescia; Patrizia Rellecati; Antonella Castagna; Cristina Mussini; Adriana Ammassari; Paola Cinque; Antonella d'Arminio Monforte
Journal:  Clin Infect Dis       Date:  2004-11-05       Impact factor: 9.079

9.  Guidelines for the diagnosis and management of neurological complications of HIV infection.

Authors:  P Portegies; L Solod; P Cinque; A Chaudhuri; J Begovac; I Everall; T Weber; M Bojar; P Martinez-Martin; P G E Kennedy
Journal:  Eur J Neurol       Date:  2004-05       Impact factor: 6.089

Review 10.  Toxoplasma gondii: transmission, diagnosis and prevention.

Authors:  D Hill; J P Dubey
Journal:  Clin Microbiol Infect       Date:  2002-10       Impact factor: 8.067

View more
  4 in total

1.  Literature review and case histories of Histoplasma capsulatum var. duboisii infections in HIV-infected patients.

Authors:  Pierre Loulergue; Frédéric Bastides; Véronique Baudouin; Jacques Chandenier; Patricia Mariani-Kurkdjian; Bertrand Dupont; Jean-Paul Viard; Françoise Dromer; Olivier Lortholary
Journal:  Emerg Infect Dis       Date:  2007-11       Impact factor: 6.883

2.  Unmasking histoplasmosis immune reconstitution inflammatory syndrome in a patient recently started on antiretroviral therapy.

Authors:  Reuben Kiggundu; Henry W Nabeta; Richard Okia; Joshua Rhein; Robert Lukande
Journal:  Autops Case Rep       Date:  2016-12-30

Review 3.  Histoplasmosis in Africa: Current perspectives, knowledge gaps, and research priorities.

Authors:  Bright K Ocansey; Chris Kosmidis; Martin Agyei; Améyo M Dorkenoo; Olusola O Ayanlowo; Rita O Oladele; Tchin Darre; David W Denning
Journal:  PLoS Negl Trop Dis       Date:  2022-02-24

4.  Histoplasmosis with Deep CNS Involvement: Case Presentation with Discussion and Literature Review.

Authors:  Omid R Hariri; Tanya Minasian; Syed A Quadri; Anya Dyurgerova; Saman Farr; Dan E Miulli; Javed Siddiqi
Journal:  J Neurol Surg Rep       Date:  2015-06-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.